Zenodo
What is the effect of oral administration of hyoscine butylbromide on reducing secretions in patients with hypersecretory conditions?
By Tripdatabase.
Abstract
No direct evidence for the oral administration of hyoscine butylbromide in reducing secretions in patients with hypersecretory conditions; its known properties as an anticholinergic may offer some rationale, largely based on mechanism rather than direct clinical evidence.
Keywords
- Medical research and treatments
- hyoscine butylbromide
- oral administration
- hypersecretion
- anticholinergic agents
- Open access